Stockscreener 앱 받기
46.22
2.61%
-1.24
시간 외 거래:
46.01
-0.21
-0.45%
전일 마감가:
$47.46
열려 있는:
$47.32
하루 거래량:
710.76K
Relative Volume:
0.61
시가총액:
$3.70B
수익:
-
순이익/손실:
$-269.44M
주가수익비율:
-12.33
EPS:
-3.75
순현금흐름:
$-262.63M
1주 성능:
+0.04%
1개월 성능:
-1.72%
6개월 성능:
+2.17%
1년 성능:
+65.07%
1일 변동 폭
$46.16
$47.32
1주일 범위
$44.53
$48.44
52주 변동 폭
$21.34
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
명칭
Akero Therapeutics Inc
전화
650-487-6488
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
46.22 | 3.80B | 0 | -269.44M | -262.63M | -3.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-08-04 | 개시 | TD Cowen | Buy |
| 2025-01-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-18 | 개시 | Citigroup | Buy |
| 2024-04-22 | 재개 | BofA Securities | Neutral |
| 2023-09-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-10-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-02-26 | 개시 | Guggenheim | Buy |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2020-07-01 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-02 | 개시 | H.C. Wainwright | Buy |
| 2020-02-10 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Evercore ISI | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
| 2019-07-15 | 개시 | Jefferies | Buy |
| 2019-07-15 | 개시 | ROTH Capital | Buy |
모두보기
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience - The Globe and Mail
Akero Therapeutics, Inc. $AKRO Shares Acquired by Voya Investment Management LLC - MarketBeat
Strs Ohio Acquires New Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics (NASDAQ:AKRO) Shares Gap UpTime to Buy? - MarketBeat
Akero Therapeutics, Inc. $AKRO Shares Bought by Intech Investment Management LLC - MarketBeat
Earnings Risk: Will Akero Therapeutics Inc outperform the market in YEAR2025 Investor Takeaways & Target Return Focused Stock Picks - خودرو بانک
Risk Analysis: Does Esperion Therapeutics Inc align with a passive investing strategyMarket Activity Recap & Fast Entry High Yield Stock Tips - خودرو بانک
Akero Therapeutics (AKRO) Receives a Buy from Canaccord Genuity - The Globe and Mail
Fundamentals Check: Does Akero Therapeutics Inc meet Warren Buffetts criteriaTrade Signal Summary & AI Enhanced Trading Alerts - khodrobank.com
FOMO Trade: How does Akero Therapeutics Inc. score in quality rankingsStock Surge & Stock Market Timing Techniques - خودرو بانک
CCORF Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $73 - 富途牛牛
NTLA Completes Enrollment in Pivotal Study on HAE Candidate, Stock Up - sharewise.com
Hedge Fund Bets: Does Akero Therapeutics Inc. have consistent dividend growthWeekly Trade Review & Long-Term Growth Stock Strategies - خودرو بانک
Morgan Stanley Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $84 - 富途牛牛
Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023 - FinancialContent
AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER - GlobeNewswire
Pharma News: Why is Akero Therapeutics Inc stock going downJuly 2025 Patterns & Reliable Price Action Trade Plans - خودرو بانک
EV Market: What is the next catalyst for Northern Dynasty Minerals LtdTrade Exit Report & Weekly Breakout Stock Alerts - khodrobank.com
Momentum Shift: Is PEBPRH stock a falling knife or bargain buyJuly 2025 Market Mood & Community Consensus Trade Signals - khodrobank.com
Akero Therapeutics (NASDAQ:AKRO) Rating Lowered to Sell at Wall Street Zen - MarketBeat
LifeSci Capital Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Aug Update: Can Apollomics Inc. Equity Warrant deliver consistent EPS growthJuly 2025 Setups & Safe Entry Trade Signal Reports - khodrobank.com
Gains Report: Is Akero Therapeutics Inc backed by strong institutional buyingJuly 2025 Institutional & Technical Buy Zone Confirmations - khodrobank.com
Aug EndMonth: Can CHARR ride the EV waveForecast Cut & Free Reliable Trade Execution Plans - khodrobank.com
Analyst Calls: What is the implied volatility of Roundhill Etf Trust Roundhill Aapl Weeklypay EtfSell Signal & Free Growth Oriented Trading Recommendations - khodrobank.com
Woodline Partners LP Acquires 100,769 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Block Trades: Should you avoid Akero Therapeutics Inc stock right nowWeekly Volume Report & AI Driven Stock Reports - khodrobank.com
Aug Spikes: Is Akero Therapeutics Inc stock good for income investorsMarket Sentiment Summary & Growth Focused Investment Plans - خودرو بانک
Winners Losers: What is Akero Therapeutics Incs revenue forecastWeekly Profit Recap & Daily Profit Maximizing Tips - خودرو بانک
Aug Opening: Is Akero Therapeutics Inc stock influenced by commodity prices2025 Retail Activity & Low Risk High Win Rate Stock Picks - خودرو بانک
Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update - The Globe and Mail
Analyst Calls: Is Akero Therapeutics Inc part of any major indexPortfolio Return Summary & Weekly High Conviction Ideas - خودرو بانک
Risk Check: Can NDAQ sustain earnings growthTrade Signal Summary & Comprehensive Market Scan Insights - khodrobank.com
Can Akero Therapeutics Inc deliver alphaMarket Activity Summary & Free Long-Term Investment Growth Plans - خودرو بانک
Portfolio Shifts: What is Baker Hughes Company’s TAM (Total Addressable Market)July 2025 Market Mood & Real-Time Market Trend Scan - خودرو بانک
Death Cross: Can Akero Therapeutics Inc stock outperform in a bear marketJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - خودرو بانک
Update Recap: Why is Akero Therapeutics Inc stock going downGap Up & Weekly Top Performers Watchlists - خودرو بانک
Akero Therapeutics (NASDAQ:AKRO) Insider Timothy Rolph Sells 12,500 Shares - MarketBeat
Downgrade Watch: Is ProShares Trust ProShares Ultra Communication Services stock a buy or sellWeekly Gains Report & Expert-Curated Trade Recommendations - خودرو بانک
Day Trade: Will Akero Therapeutics Inc benefit from government policyJuly 2025 Chart Watch & Accurate Entry/Exit Alerts - خودرو بانک
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? - sharewise.com
Momentum Shift: What hedge funds are buying Akero Therapeutics IncJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - خودرو بانک
Aug Patterns: Does Akero Therapeutics Inc offer margin of safety2025 Stock Rankings & Consistent Growth Equity Picks - خودرو بانک
Buyout Rumor: Is Akero Therapeutics Inc part of any major index2025 Trade Ideas & Long-Term Growth Stock Strategies - خودرو بانک
Market Fear: Is Akero Therapeutics Inc. stock a falling knife or bargain buyJuly 2025 Summary & Reliable Intraday Trade Alerts - خودرو بانک
US Market Wrap: Will M tron Industries Inc benefit from sector rotation2025 Breakouts & Breakdowns & AI Forecast Swing Trade Picks - khodrobank.com
Market Wrap: What is the earnings history of Akero Therapeutics IncQuarterly Trade Summary & AI Optimized Trading Strategy Guides - خودرو بانک
Akero Therapeutics Inc. stock prediction for this weekCEO Change & Entry Point Confirmation Signals - newser.com
Fred Alger Management LLC Grows Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Exome Asset Management LLC Boosts Stake in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics COO sells $25k in shares By Investing.com - Investing.com South Africa
Akero Therapeutics Inc (AKRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):